Anaemedia Frequently Asked Questions (FAQ)
What is Anaemedia's latest funding round?
Anaemedia's latest funding round is Incubator/Accelerator.
Who are the investors of Anaemedia?
Investors of Anaemedia include Centre for Innovation Incubation and Entrepreneurship.
Who are Anaemedia's competitors?
Competitors of Anaemedia include Senseonics, Powervision, TruTouch Technologies, EyeTechCare, Corpora Systems and 7 more.
Compare Anaemedia to Competitors
Realistic Eye aims to provide a more natural appearance for the 750,000 patients in the US with an artificial eye that does not dilate and therefore appears unnatural. RealisticEye achieves these results by introducing a dilating artificial eye.
Verimetra aims to make medical instruments "smart" and manufacturers miniature thin film sensors used in medical applications that involve very small high end catheters. The Company designs and manufactures sensors using micro-electromechanical systems (MEMS) technology, which is the only method available that produces sensors small enough to be embedded in surgical devices without changing their basic form or function, allowing the company's customers to sell the same products, now "smart", without requiring the surgeon to use a new device. Verimetra aims to make medical devices "smart" by embedding (US Patent 6,494,882) a variety of small sensors at an place on or within the device. Simply stated, the company make "dumb" metal tools "smart". Examples include forceps, grippers, retractors, drills, and other surgical devices. Through the use of Verimetra's products, medical device manufacturers are able to deliver features and functionality that, depending on the medical procedure, improve outcomes, reduce risk and shorten patient recovery times. Verimetra's new product features are also used by manufacturers to strengthen their market position, enter new markets and maintain gross margins. Verimetra aims to give these manufacturers a way to accomplish these goals by adding features at a low cost without product redesign. Furthermore, in many instances, Verimetra's customers' goals will be met by the transformation of a re-usable product (one-time sale) into a smart disposable product (one sale per procedure).
OcuSciences is developing a product to use images from the eye to detect diseases such as diabetes at an earlier stage.
Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.
eSight is a company that focuses on low-vision assistive technology within the healthcare industry. The company's main product is a pair of smart glasses that enhance the vision of individuals with significant central vision loss, using a high-speed camera and advanced algorithms to optimize and enhance real-time footage. The company primarily serves the healthcare sector, particularly eye care professionals and individuals with various eye conditions. It was founded in 2006 and is based in Toronto, Ontario.
Innovia Earcheck Middle Ear Monitor manufactures medical devices. It develops acoustic otoscopes to measure middle ear fluid and detect ear infections. The company is based in Lincoln, Nebraska.